Brief: Arctic Bioscience Says Clinical Trial Application For Hro350 Phase IIb Approved In The UK

Arctic Bioscience AS

12/01/2023 17:24

Jan 12 (Reuters) - Arctic Bioscience AS  ABSA.OL :
    * ARCTIC BIOSCIENCE - CLINICAL TRIAL APPLICATION FOR HRO350
PHASE
IIB APPROVED IN THE UK
    * ARCTIC BIOSCIENCE-CTA WAS SIMULTANEOUSLY ALSO APPROVED BY
UNITED
KINGDOM MEDICINES & HEALTHCARE PRODUCTS REGULATORY AGENCY, UK
RESEARCH ETHICS COMMITTEE
    * ARCTIC BIOSCIENCE - CURRENTLY IN THE PROCESS OF ACTIVATING
THE
CLINICAL TRIAL SITES IN THE UK, & FIRST PATIENT INCLUSION IS
EXPECTED LATER THIS MONTH

Source text for Eikon:  ID:nWkr74pcQ7 
Further company coverage:  ABSA.OL 
 ((Reuters.Briefs@thomsonreuters.com;))